Emmaus Life Sciences appoints Lori Teranishi as director

Emmaus Life Sciences, Inc.

Board expanded from 7 to 8 on Jan 6, 2022; Teranishi appointed.
Teranishi is founder & CEO of iQ 360, a strategic communications firm.
She will receive standard non-employee director compensation per proxy.
Expected to join board committees when schedule allows.
No family relationships or related-party transactions disclosed.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Lori Teranishi

director

EMMA · Emmaus Life Sciences, Inc.

Effective: 2022-01-06
Filed: January 10, 2022, 6:59 PM ET

expanded the number of directors from seven to eight and appointed Lori Teranishi as a director of the company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Lori Teranishi was appointed as director at Emmaus Life Sciences, Inc..

Action: appointed
Role: director

Exact text from the filing

expanded the number of directors from seven to eight and appointed Lori Teranishi as a director of the company.

View on SEC.gov

Emmaus Life Sciences, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-22-001304

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.